ask="2.85"
ask_size="400"
average_daily_volume="1024250"
bid="2.35"
bid_size="1000"
book_value="0.29"
change="-0.02"
change_from_200_day_moving_average="0.80"
change_from_50_day_moving_average="0.39"
change_from_52_week_high="-0.10"
change_From_52_week_low="2.10"
change_in_percent="-0.71%"
close="2.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.16"
ebitda="-22.29M"
eps_estimate_current_year="-0.09"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="0.08"
ex_dividend_date="N/A"
float_shares="116731000"
high="2.90"
high_52_weeks="2.90"
last_trade_date="3/17/2017"
last_trade_price="2.80"
last_trade_size="124192"
last_trade_time="4:00pm"
low="2.77"
low_52_weeks="0.70"
market_capitalization="434.31M"
moving_average_200_day="2.00"
moving_average_50_day="2.41"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="4.00"
open="2.81"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+40.35%"
percent_change_from_50_day_moving_average="+16.02%"
percent_change_from_52_week_high="-3.45%"
percent_change_from_52_week_low="+300.00%"
previous_close="2.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="35.00"
price_per_book="9.66"
price_per_sales="8.38"
revenue="52.22M"
shares_outstanding="155110000"
short_ratio="2.32"
stock_exchange="NCM"
symbol="ATRS"
volume="1842961"
weeks_range_52="0.70 - 2.90"
